TOFACITINIB for Systemic scleroderma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 17 adverse event reports in the FDA FAERS database where TOFACITINIB was used for Systemic scleroderma.

Most Reported Side Effects for TOFACITINIB

Side Effect	Reports	%	Deaths	Hosp.
Drug ineffective	30,382	19.5%	1,308	4,132
Pain	21,659	13.9%	1,649	4,320
Condition aggravated	16,925	10.9%	1,441	3,639
Arthralgia	15,640	10.1%	1,460	3,384
Fatigue	13,551	8.7%	1,643	3,450
Rheumatoid arthritis	12,277	7.9%	1,669	3,200
Off label use	11,736	7.5%	1,767	3,218
Headache	11,061	7.1%	1,302	2,294
Joint swelling	10,686	6.9%	1,703	2,877
Malaise	9,040	5.8%	1,306	2,561
Rash	8,889	5.7%	1,641	2,886
Pain in extremity	8,675	5.6%	905	1,915
Abdominal discomfort	7,966	5.1%	1,393	2,378
Diarrhoea	7,925	5.1%	1,316	2,246
Peripheral swelling	7,830	5.0%	1,256	2,295